Comments
Loading...

Corcept Therapeutics

CORTNASDAQ
Logo brought to you by Benzinga Data
$57.49
-0.05-0.09%
Pre-Market: 6:54 AM EDT

Corcept Therapeutics (NASDAQ:CORT) Stock, Earnings Estimates, EPS, And Revenue

Corcept Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 13
EPS Estimate
$0.270
Quarterly Revenue Estimate
$176.3M
Annual Revenue
(as of Sep 30)
$628.6M

Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Corcept Therapeutics (CORT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-30$0.41$0.2846.4 %
Jun 20242024-07-29$0.32$0.2339.1 %
Mar 20242024-05-01$0.25$0.2213.6 %
Dec 20232024-02-15$0.28$0.267.69 %

Corcept Therapeutics (CORT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-10-30$182.55M$171.97M6.15 %
Jun 20242024-07-29$163.77M$155.23M5.50 %
Mar 20242024-05-01$146.81M$140.80M4.27 %
Dec 20232024-02-15$135.41M$129.30M4.72 %

FAQ

Q

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

A

Corcept Therapeutics (CORT) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Corcept Therapeutics (NASDAQ:CORT)?

A

The Actual EPS was $0.41, which beat the estimate of $0.28.

Q

What were Corcept Therapeutics’s (NASDAQ:CORT) revenues?

A

The Actual Revenue was $182.5M, which beat the estimate of $172M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch